過敏性腸症候群（IBS）治療の世界市場レポート 2023年以下を含む：1) 薬剤タイプ別ルビプロストン; リナクロチド; エルクサドリン; リファキシミン; アロセトロン2) 適応症別：便秘を伴うIBS; 下痢を伴うIBS; 便秘と下痢を交互に伴うIBS3) 販売チャネル別：病院薬局；オンライン薬局；小売薬局4) エンドユーザー別病院; クリニック; 在宅ケア設定対象：ファイザー；ジョンソン・エンド・ジョンソン；アッヴィ；ノバルティス；アストラゼネカ

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2023Including: 1) By Drug Type: Lubiprostone; Linaclotide; Eluxadoline; Rifaximin; Alosetron2) By Indication: IBS With Constipation; IBS With Diarrhea; IBS With Alternating Constipation And Diarrhea3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies4) By End-Users: Hospitals; Clinics; Homecare SettingsCovering: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Novartis AG; AstraZeneca plc

The Business Research Companyの過敏性腸症候群（IBS）治療の世界市場レポート2023は、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。このレポートは力強い... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年9月21日	US$5,000 シングルユーザライセンスライセンス・価格情報注文方法はこちら	175	英語

サマリー

The Business Research Companyの過敏性腸症候群（IBS）治療の世界市場レポート2023は、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

このレポートは力強い成長を遂げている過敏性腸症候群（IBS）治療市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。

購入の理由
- 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。
- ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。
- 世界的な高インフレが市場成長に与える影響を測定する。
- 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。
- 最新の市場シェアに基づいて顧客を理解する。
- 主要な競合他社に対する業績のベンチマーク
- 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。
- レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。
- レポートの全データは、エクセルのダッシュボード形式でも納品されます。

説明
過敏性腸症候群（ibs）治療の最大かつ急成長市場はどこか？経済全体、人口動態、他の類似市場との関連は？今後の市場を形成する勢力は何か？この調査レポートは過敏性腸症候群（ibs）治療薬の世界市場を分析・予測したBusiness Research Companyの市場調査報告書です。

市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、動向、戦略などを網羅しています。地域別に市場の過去および予測市場成長を追跡します。

調査範囲

対象市場：1) 薬剤タイプ別ルビプロストン；リナクロチド；エルキサドリン；リファキシミン；アロセトロン；その他薬剤
2) 適応症別便秘を伴うIBS；下痢を伴うIBS；便秘と下痢を交互に伴うIBS
3) 販売チャネル別病院薬局；オンライン薬局；小売薬局
4) エンドユーザー別病院；診療所；在宅医療の現場

言及された企業ファイザー社、ジョンソン・エンド・ジョンソンサービス社、アッヴィ社、ノバルティス社、アストラゼネカ社

国オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、

データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

納品形式PDF、Word、Excel データダッシュボード。

ページTOPに戻る

1. Executive Summary
2. Irritable Bowel Syndrome (IBS) Treatment Market Characteristics
3. Irritable Bowel Syndrome (IBS) Treatment Market Trends And Strategies
4. Irritable Bowel Syndrome (IBS) Treatment Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Irritable Bowel Syndrome (IBS) Treatment Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Irritable Bowel Syndrome (IBS) Treatment Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Irritable Bowel Syndrome (IBS) Treatment Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Irritable Bowel Syndrome (IBS) Treatment Market Segmentation
6.1. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Lubiprostone
Linaclotide
Eluxadoline
Rifaximin
Alosetron
Other Drugs
6.2. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
IBS With Constipation
IBS With Diarrhea
IBS With Alternating Constipation And Diarrhea
6.3. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
6.4. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Clinics
Homecare Settings
7. Irritable Bowel Syndrome (IBS) Treatment Market Regional And Country Analysis
7.1. Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market
8.1. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Irritable Bowel Syndrome (IBS) Treatment Market
9.1. China Irritable Bowel Syndrome (IBS) Treatment Market Overview
9.2. China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Irritable Bowel Syndrome (IBS) Treatment Market
10.1. India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Irritable Bowel Syndrome (IBS) Treatment Market
11.1. Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Irritable Bowel Syndrome (IBS) Treatment Market
12.1. Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market
13.1. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Irritable Bowel Syndrome (IBS) Treatment Market
14.1. South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market
15.1. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market Overview
15.2. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Irritable Bowel Syndrome (IBS) Treatment Market
16.1. UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Irritable Bowel Syndrome (IBS) Treatment Market
17.1. Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Irritable Bowel Syndrome (IBS) Treatment Market
18.1. France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Irritable Bowel Syndrome (IBS) Treatment Market
19.1. Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Irritable Bowel Syndrome (IBS) Treatment Market
20.1. Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market
21.1. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market Overview
21.2. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Irritable Bowel Syndrome (IBS) Treatment Market
22.1. Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Irritable Bowel Syndrome (IBS) Treatment Market
23.1. North America Irritable Bowel Syndrome (IBS) Treatment Market Overview
23.2. North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Irritable Bowel Syndrome (IBS) Treatment Market
24.1. USA Irritable Bowel Syndrome (IBS) Treatment Market Overview
24.2. USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Irritable Bowel Syndrome (IBS) Treatment Market
25.1. Canada Irritable Bowel Syndrome (IBS) Treatment Market Overview
25.2. Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Irritable Bowel Syndrome (IBS) Treatment Market
26.1. South America Irritable Bowel Syndrome (IBS) Treatment Market Overview
26.2. South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Irritable Bowel Syndrome (IBS) Treatment Market
27.1. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Irritable Bowel Syndrome (IBS) Treatment Market
28.1. Middle East Irritable Bowel Syndrome (IBS) Treatment Market Overview
28.2. Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Irritable Bowel Syndrome (IBS) Treatment Market
29.1. Africa Irritable Bowel Syndrome (IBS) Treatment Market Overview
29.2. Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Irritable Bowel Syndrome (IBS) Treatment Market Competitive Landscape And Company Profiles
30.1. Irritable Bowel Syndrome (IBS) Treatment Market Competitive Landscape
30.2. Irritable Bowel Syndrome (IBS) Treatment Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson Services Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. AbbVie Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Novartis AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. AstraZeneca plc
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Irritable Bowel Syndrome (IBS) Treatment Market Other Major And Innovative Companies
31.1. Abbott Laboratories
31.2. Takeda Pharmaceutical Company Limited
31.3. Eli Lilly and Company
31.4. Amgen Inc.
31.5. Astellas Pharma Inc.
31.6. Biogen Inc.
31.7. Bausch Health Companies Inc.
31.8. UCB SA
31.9. SK Biopharmaceuticals Co. Ltd.
31.10. Celltrion Healthcare Co. Ltd
31.11. Ironwood Pharmaceuticals Inc.
31.12. Sebela Pharmaceuticals Inc.
31.13. Prometheus Laboratories Inc.
31.14. RedHill Biopharma Ltd.
31.15. Ardelyx Inc.
32. Global Irritable Bowel Syndrome (IBS) Treatment Market Competitive Benchmarking
33. Global Irritable Bowel Syndrome (IBS) Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Irritable Bowel Syndrome (IBS) Treatment Market
35. Irritable Bowel Syndrome (IBS) Treatment Market Future Outlook and Potential Analysis
35.1 Irritable Bowel Syndrome (IBS) Treatment Market In 2027 - Countries Offering Most New Opportunities
35.2 Irritable Bowel Syndrome (IBS) Treatment Market In 2027 - Segments Offering Most New Opportunities
35.3 Irritable Bowel Syndrome (IBS) Treatment Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

ページTOPに戻る

Table of Contents

Summary

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on irritable bowel syndrome (ibs) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for irritable bowel syndrome (ibs) treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The irritable bowel syndrome (ibs) treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Drug Type: Lubiprostone; Linaclotide; Eluxadoline; Rifaximin; Alosetron; Other Drugs
2) By Indication: IBS With Constipation; IBS With Diarrhea; IBS With Alternating Constipation And Diarrhea
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
4) By End-Users: Hospitals; Clinics; Homecare Settings

Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Novartis AG; AstraZeneca plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Business Research Company　(TBRC)社の医療サービス分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC)社の医療サービス分野での最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?